Gladstone Capital Corporation (GLAD)

Regulus Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	611	523	372	291	388	231
Market Cap Growth	18.97%	40.60%	27.77%	-24.87%	67.71%	-21.88%
Enterprise Value	875	847	732	568	596	456
Last Close Price	26.72	22.31	16.31	13.06	16.19	9.82
PE Ratio	8.11	5.54	8.72	14.63	4.60	-
Forward PE	13.52	11.51	8.24	9.65	14.49	9.22
PS Ratio	6.66	5.42	4.31	4.61	7.21	4.82
PB Ratio	1.26	1.09	0.91	0.92	1.22	0.99
P/TBV Ratio	1.28	1.11	0.91	0.92	1.22	0.99
P/OCF Ratio	7.11	161.48	-	-	-	-
EV/Sales Ratio	9.81	8.77	8.47	8.99	11.08	9.51
EV/EBIT Ratio	13.09	12.17	11.55	12.23	15.28	12.45
Debt / Equity Ratio	0.58	0.68	0.74	1.08	0.75	0.95
Asset Turnover	0.12	0.13	0.13	0.10	0.11	0.11
Quick Ratio	2.73	1.26	1.23	1.42	1.21	2.09
Current Ratio	2.75	1.47	1.34	1.53	1.38	2.22
Return on Equity (ROE)	16.07%	21.30%	11.78%	6.28%	30.53%	-0.78%
Return on Assets (ROA)	5.37%	5.68%	5.74%	4.73%	4.75%	5.17%
Return on Capital (ROIC)	5.44%	5.75%	5.81%	4.79%	4.82%	5.22%
Return on Capital Employed (ROCE)	8.70%	8.70%	8.90%	7.10%	6.90%	8.00%
Earnings Yield	12.35%	18.06%	11.47%	6.84%	21.75%	-0.81%
Dividend Yield	7.24%	8.88%	11.31%	11.64%	9.64%	16.50%
Payout Ratio	70.53%	45.65%	82.98%	137.20%	30.81%	-
Buyback Yield / Dilution	-4.32%	-16.74%	-8.63%	-3.36%	-7.07%	-6.05%
Total Shareholder Return	2.97%	-7.86%	2.68%	8.28%	2.57%	10.45%

Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q